Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.
Metrics to compare | FLRY3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFLRY3PeersSector | |
---|---|---|---|---|
P/E Ratio | 12.8x | 15.9x | −0.6x | |
PEG Ratio | 7.32 | 0.61 | 0.00 | |
Price/Book | 1.4x | 0.7x | 2.6x | |
Price / LTM Sales | 1.0x | 0.7x | 3.3x | |
Upside (Analyst Target) | 5.5% | 27.7% | 37.4% | |
Fair Value Upside | Unlock | 16.9% | 4.5% | Unlock |